Deal Roundup: Carlyle, CVC strike €1bn BauWatch deal, HIG agrees $866m Mistras take-private
Carlyle and CVC DIF to acquire 90% of BauWatch for €1bn, with Haniel retaining 10%. HIG Capital to take Mistras Group private for $866m, or $20.35 per share. Searchlight Capital to finance $1.6bn take-private of Priority Technology at $8.05 per share. Peugeot Invest invests $175m in Mérieux NutriSciences. Thrive Capital distributes 6.3m Oscar Health shares to LPs. Rainmaker raises $100m Series B. Generate Capital sells 12 anaerobic digestion sites.
How this was made
The 30-second read
Why it matters
These deals represent significant capital deployment and ownership shifts, offering immediate trading opportunities around deal announcements.
Market read
M&A announcements drive short‑term price moves; investors should monitor deal completion milestones.
What to watch
Regulatory approvals for the Mistras take‑private and potential antitrust scrutiny in health‑tech.
Background
The article aggregates several newly announced private‑equity and strategic transactions across Europe and the US.
Market effects
Private‑equity activity signals continued consolidation in industrial testing and health‑tech sectors.
European security market sees new private‑equity backing; US health‑tech faces higher insider ownership.
Large‑scale M&A deals influence global capital allocation trends across technology and industrial sectors.
Counterpoint
Deal premiums may be overstated; post‑close integration risks could depress long‑term returns.
Key entities
- Private Equity FirmHIG Capital
Acquirer of Mistras Group.
- Venture Capital FirmThrive Capital
Distributor of Oscar Health shares to its LPs.


